Navigation Links
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
Date:1/30/2013

venue from the acquired whole blood business.
  • $16 million of share repurchases; $21 million year-to-date.
  • Completion of two-for-one stock split.
  • A revenue breakdown follows:

    Plasma

    Plasma disposables revenue was $68.1 million for the quarter, down 1%, and $200.7 million year-to-date, up 2%.  Fiscal 2012 third quarter plasma revenue was very strong representing a challenging comparable year over year.  On the strength of a high-single digit percentage growth forecast for the fourth quarter, the Company expects its plasma business growth to be at the lower end of the previously estimated range of 4-6% in fiscal 2013.

    Blood Center

    Platelet disposables revenue was $45.1 million for the quarter, up 2%, and $125.6 million year-to-date, up 1%, with continued benefit from strong sales in emerging markets.  Red cell disposables revenue was $11.8 million for the quarter, down 3%, and $35.8 million year-to-date, flat with the prior year period.  Red cell disposables revenue was flat with the prior year on a year-to-date basis in a soft market as the Company leveraged its IMPACT® selling approach to advance Blood Management Solutions.  The Company expects its blood center revenue to be flat organically in fiscal 2013. 

    Whole blood revenue was $54.9 million for the quarter and $83.5 million year-to-date, in line with expectations, and the Company is affirming its previous guidance for whole blood revenue of $135-$145 million for fiscal 2013.Hospital

    Surgical disposables revenue was $18.9 million for the quarter, up 9%, and $56.0 million year-to-date, up 14%.  Notably, this was the sixth consecutive quarterly increase as the Cell Saver Elite device continues to capture market share.  Recent strong equipment sales, including a 77% year-to-date increase in China, drove near term disposables growth. 

    Disposables revenue from the OrthoPAT&
    '/>"/>

    SOURCE Haemonetics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine technology :

    1. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
    2. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
    3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
    4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
    5. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
    6. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
    7. Danaher Reports Record Fourth Quarter 2012 Results
    8. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
    9. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
    10. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
    11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. For the ... on the corporate reputation of the pharmaceutical industry held ... with the views of patient organisations representing all therapy ...
    (Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... the first quarter of 2015 on Wednesday, May 6, ... Company will host a conference call at 4:30 PM ... management will discuss the first quarter 2015 financial results ...
    (Date:4/16/2015)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report ... Wednesday, May 6, 2015, following the close of the U.S. ... call and live webcast on the same day at 5:00 ... the financial results.  To access the webcast ... "Investors" link.  Please log onto the webcast prior to the ...
    Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
    ... 2011 Unilife Corporation ("Unilife" or the "Company") (Nasdaq: ... be presenting at Cowen and Company,s 31st Annual Health Care ... Boston. Alan Shortall, Chief Executive Officer of Unilife, is scheduled ... 2011. The conference presentation will be broadcast over ...
    ... VICTOR, N.Y., March 7, 2011 PharmaNova, Inc. ... whereby Lacerta Bio,s experienced team of business development ... and U.K. to support its 2011 business growth ... PharmaNova,s partnering base for its innovative, nanoparticle technology, ...
    Cached Medicine Technology:Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston 2PharmaNova Fuels Business Growth with Lacerta Bio Partnership 2
    (Date:4/17/2015)... From the day Dr. Todd Phillips founded The Last ... empowered young people to create meaningful change in their world. ... and the Gospel to all of Liberia by 2020 , ... 27, students, faculty and staff raised $21,000 through the TEN ... the Good News of Jesus. , During the campaign, ...
    (Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed Royce ... 1849 in congress on April 16, 2015 in an ... with the genetic disease. , The bill, similar ... first to create a federally led and financed initiative ... telangiectasia. This would effectively prevent premature death and disability ...
    (Date:4/17/2015)... Hollywood, California (PRWEB) April 17, 2015 ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... the luxurious Beverly Hilton Hotel, overlooking the impressive Los ... nominees were organized by Debbie Durkin, LA’s leading producer ... , Showcasing many of the world’s premier providers of ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
    (Date:4/17/2015)... 2015 The American College of Traditional Chinese Medicine ... Day on April 29. The event will be held from 11 ... 555 DeHaro St. in San Francisco, CA. , The agenda for ... at the DeHaro campus (room F), 11:10 a.m. – Introduction ... – Light lunch with current students, faculty and staff, 1 p.m. ...
    Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:American College of Traditional Chinese Medicine Hosts Open House 2
    ... For patients with,rheumatoid arthritis, combining one well-known, lower ... works best to reduce joint,swelling or tenderness, according to ... and Quality, part of the U.S. Department of Health ... be posted on-line,Monday in the Annals of Internal Medicine., ...
    ... Minn., Nov. 19 Regions Hospital today was,named one ... care based on the Cardiovascular Benchmarks for Success,Study by ... 100 hospital comes as a result of the hard ... with the,excellent care provided to patients and an investment ...
    ... guide development, scientists say , MONDAY, Nov. 19 (HealthDay News) ... embryonic cells regulate levels of retinoic acid, a derivative of ... embryo development, acting as a signal between cells to control ... embryos that get too much or too little retinoic acid ...
    ... 19 Smith & Nephew,s,(NYSE: SNN ) (LSE: ... business to InaVein LLC, a Boston-area investor group led ... medical,device marketplace. Terms of the sale were not disclosed. ... product portfolio,as part of Smith & Nephew,s overall Earnings ...
    ... OMCL ) a leading provider of systems and ... today announced that Randall A. Lipps, chairman, president &,CEO ... at the Piper Jaffray,19th Annual Health Care Conference at ... scheduled to begin at 12:00 p.m. on Wednesday,November 28, ...
    ... different than men,s way beyond their reproductive systems. Women wake ... and are more likely to suffer from depression and sleep ... , Yet, there,s a cavernous void in research based ... on men and the findings applied to women. , ...
    Cached Medicine News:Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 3Health News:Research Reveals Nutrient's Impact on the Embryo 2Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 2Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 3Health News:Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference 2Health News:Women aren't men 2Health News:Women aren't men 3
    The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
    The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
    The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
    ... Impulse II lead series are silicon ... extend the longevity of the pacemaker ... The high impedance of the lead ... electrode surface, combined with the elution ...
    Medicine Products: